Sangamo Biosciences (NASDAQ: SGMO) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $12.5 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.